A new test for two blood cancers developed by a team at Washington University School of Medicine in St. Louis is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Service
A new test for two blood cancers – developed by a team at Washington University School of Medicine in St. Louis – is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services.